Ann Arbor's 9.6-point obesity gap under Michigan, a withdrawn low-income HPSA, two academic specialist systems in town, and a local self-pay price of $225 to $750 a month.
Ann Arbor's adult obesity prevalence is 25.8% (CDC PLACES 2025 release, BRFSS 2023) 1 against Michigan's 35.4% 2, a 9.6-point gap. With 122,914 residents in a 369,822-person metro, a 3.5% uninsured rate, and an $80,603 median household income, this is one of the best-covered, highest-income markets in this rollout 346.
So this is not an access-gap page. Washtenaw County has two specialist systems in town. The question here is only price, and the local self-pay floor is $225/month 9.
MDHHS pharmacy and PDL pages returned HTTP 403 on every direct check this session, so live coverage rules could not be pulled from the source portal. What the state's official Pharmacy Provider Manual, effective July 1, 2026 with sections marked "Change Made 4/1/2026," does confirm is that Michigan Medicaid maintains a distinct "Anti-Obesity" prior-authorization drug category separate from any diabetes-specific PA category 10. Coverage is therefore not limited by default to a type 2 diabetes diagnosis.
The manual states the specific clinical and PDL criteria for that category are set by MDHHS's contracted Pharmacy Benefits Administrator, and that vendor's criteria document was not located this session 10. Confirm with MDHHS directly before relying on a specific weight-loss approval rule. This affects Medicaid enrollees only; Astra's self-pay rate is the same nationwide regardless of insurance status.
Restore Hyper Wellness's Ann Arbor studio at 3225 Washtenaw Ave runs a self-pay compounded semaglutide or tirzepatide program at $225 to $750/month depending on medication and dose, including an initial qualification consult and ongoing NP telemed visits, with a choice of in-studio injection, studio pickup, or home delivery. The site states plainly that it does not take insurance 89.
That is a real, published number, which is rarer than it should be, and it is also the number to measure against. Astra's price is national and identical everywhere it is licensed: $68/month for compounded semaglutide and $118/month for compounded tirzepatide, both on 12-month plans billed annually at $816 and $1,416. There is no Ann Arbor rate, no local discount, and no consult required to find out the number. At the bottom of Restore's range the local floor is roughly two times Astra's semaglutide plan; at the top it is roughly six times.
Ann Arbor is home to Michigan Medicine, the University of Michigan's academic health system, and to IHA/Trinity Health Michigan, both running endocrinology and weight-management programs locally. Unlike most tier-2 cities in this rollout, Ann Arbor is not specialist-poor on paper. Current new-patient wait times at either system could not be independently verified this session, since both program pages returned HTTP 403, so no wait-time figure is asserted here.
The shortage picture is similarly thin. No general-population Primary Care HPSA is active for Ann Arbor. The one geography-based designation touching the city, "LI-Ann Arbor/Ypsilanti SA" (score 12, ratio about 5,789:1), is listed as Proposed For Withdrawal as of 09/22/2025, meaning it is being removed rather than newly found 7. A facility-specific Primary Care HPSA remains Designated at Packard Health, Inc., an FQHC, score 17, designated 08/18/2019, reflecting that clinic's low-income panel rather than the city at large 7.
Telehealth here is not filling a hole in supply; it removes the wait-time question and the price question at once. Astra serves all 50 states, including Michigan.
Astra treats patients in Michigan through state-licensed physicians.
The one Ann Arbor provider confirmed to publish self-pay GLP-1 pricing, Restore Hyper Wellness (3225 Washtenaw Ave), charges $225–$750/month for compounded semaglutide or tirzepatide and does not accept insurance. Astra's national 12-month plans run $68/month for semaglutide and $118/month for tirzepatide — the same price in Ann Arbor as everywhere else Astra operates.
Yes. Astra's 12-month plan pricing ($68/mo semaglutide, $118/mo tirzepatide) undercuts Restore Hyper Wellness's published $225–$750/month self-pay range by roughly 2x to 6x. Astra doesn't set a different price for Ann Arbor — it's the same national rate in every city.
No — Ann Arbor's obesity rate is 25.8% (crude prevalence, BRFSS 2023), 9.6 percentage points below Michigan's statewide rate of 35.4%. That's one of the widest city-vs-state obesity gaps among the cities in this rollout, consistent with Ann Arbor's higher income and education profile relative to the state as a whole.
Michigan Medicaid's official Pharmacy Provider Manual (revised April 2026) shows a dedicated Anti-Obesity prior-authorization drug category, meaning coverage isn't automatically limited to a diabetes diagnosis. The exact drug-level criteria are set by the state's contracted pharmacy benefits administrator and weren't independently confirmed as of this writing — check directly with MDHHS if you're a Medicaid enrollee. Astra's self-pay pricing ($68–$118/mo) applies the same way regardless of insurance status.
No specialist visit is required. While Ann Arbor has both Michigan Medicine and IHA/Trinity Health running local endocrinology and weight-management programs, Astra's licensed telehealth clinicians can evaluate and prescribe online without an in-person visit or referral.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.